Michael E Colvin

Massachusetts General Hospital

$450,927

Attributed

$450,927

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $155.4K · FY2005–06

$200K$150K$100K$50K$0

'05

'06

Funding mix

By agency

NIH$450,927 · 6

By mechanism

P01$450,927 · 4

U19$0 · 2

Top collaborators

No co-investigators on record.

Most similar at Massachusetts General Hospital

Same institution · by research overlap

E. Antonio Chiocca$34,514,665
Nancy A Rigotti$18,154,837
Arnab Chakravarti$9,324,533
Daniel S Kohane$17,057,196
Khalid A Shah$15,720,802

Others in their field

Top investigators on “Neoplasm /Cancer Chemotherapy”

Charles A Coltman · Southwest Oncology Group$171,655,324
Norman Wolmark · Nsabp Foundation, Inc.$63,095,441
Philip J Disaia · University Of California Irvine$41,530,194
Walter J Curran · Thomas Jefferson University$37,520,030
Samuel A Wells · Duke University$32,148,803
Gregory H Reaman · National Childhood Cancer Foundation$19,436,422

Research focus

Neoplasm /Cancer ChemotherapyGliomaPharmacokineticsMicrocapsuleNeurotoxinsNonhuman Therapy EvaluationAntitumor AntibodyDextransAthymic MouseImmunotoxicityAntineoplasticsBiomedical FacilityCooperative StudyCamptothecinCarmustineNeoplasm /Cancer ImmunotherapyDiffusionDisease /Disorder ModelDrug Design /Synthesis /ProductionDrug Screening /EvaluationExotoxinsIfosfamideClone CellsPolymers